In 2023, the COVID precipice will be reached; sales to drastically fall
Pharmaceutical companies are now facing a high COVID cliff and shareholder pressure to manage their windfall profits after making billions from the epidemic over the previous two years by selling vaccines and treatments.By 2022, it is anticipated that Western pharmaceutical companies including Pfizer Inc. (PFE.N), and renowned BioNTech SE (22UAy.DE).Also: Moderna Inc. (MRNA.O), Gilead Sciences […]